General Information of Drug (ID: DMLX9SI)

Drug Name
3-[3-(2-Hydroxy-ethoxy)-phenyl]-1H-quinolin-2-one
Synonyms CHEMBL97218; AC1OCFMJ; 3-[3-(2-hydroxyethoxy)phenyl]-1H-quinolin-2-one; 3-[3-(2-Hydroxy-ethoxy)-phenyl]-1H-quinolin-2-one; ZINC13584303; BDBM50105767
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 281.3
Logarithm of the Partition Coefficient (xlogp) 2.3
Rotatable Bond Count (rotbonds) 4
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C17H15NO3
IUPAC Name
3-[3-(2-hydroxyethoxy)phenyl]-1H-quinolin-2-one
Canonical SMILES
C1=CC=C2C(=C1)C=C(C(=O)N2)C3=CC(=CC=C3)OCCO
InChI
InChI=1S/C17H15NO3/c19-8-9-21-14-6-3-5-12(10-14)15-11-13-4-1-2-7-16(13)18-17(15)20/h1-7,10-11,19H,8-9H2,(H,18,20)
InChIKey
CAPTUZLISRNFKN-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
6918599
TTD ID
D0UH0Q

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Plasmodium CDK Pfmrk (Malaria Pfmrk) TTSFWA7 P90584_PLAFA Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different class... J Med Chem. 2004 Oct 21;47(22):5418-26.